- Conditions
- Non-Ischemic Central Retinal Vein Occlusion
- Interventions
- Active bevacizumab and Sham dexamethasone, Active bevacizumab and Active dexamethasone
- Drug
- Lead sponsor
- Texas Retina Associates
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 68 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2015
- U.S. locations
- 1
- States / cities
- Dallas, Texas
Source: ClinicalTrials.gov public record
Updated Sep 24, 2025 · Synced May 21, 2026, 11:11 PM EDT